(3) Roehrborn C, Siami P, Barkin J, et al. The Effects of Dutasteride,
Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in
Men with Benign Prostatic Hyperplasia and Prostatic Enlargement: 2
Year Results from the CombAT Study. J Urol 2008 Feb; 179: 616-621.
(4) Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological
Association symptom index for benign prostatic hyperplasia. J Urol
1992 Nov; 148(5):1549-57. Accessed on January 7, 2008 via
http://www.primeanswers.org/primeanswers/calculators/bph.cfm
(5) Presti JC Jr. Neoplasms of the prostate gland. In: Tanagho EA,
McAninch JW, eds. Smith's General Urology 15th ed. New York, NY:
Lange Medical Books/McGraw-Hill Professions Division: 2000:399-421.
(6) National Institute for Diabetes and Digestive and Kidney Disease
(NIDDK). Prostate Enlargement: Benign Prostatic Hyperplasia.
http://kidney.niddk.nih.gov/kudiseases/pubs/prostateenlargement/
index.htm. Accessed on December 7, 2007.
US Media Inquiries: Rob Perry (919) 483 2839
US Analyst/Investor Inquiries: Frank Murdolo (215) 751 7002
Tom Curry (215) 751 5419
| SOURCE GlaxoSmithKline Copyright©2008 PR Newswire. All rights reserved |